15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 19.0% per year over the past 5 years.
Operating margin has contracted, at -23.5% in the latest year.
Financial health
Total debt has grown faster than revenue (-13.9% vs -19.0% per year).
Operating income covered interest expense -7167.1× in the latest year, down from -7.5× 5 years ago.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$214M
-$39M
56.6%
-23.5%
—
—
$135M
2024
$229M
-$87M
35.6%
-40.2%
—
—
$121M
2023
$307M
-$55M
53.9%
-22.0%
—
—
$199M
2022
$369M
-$106M
65.7%
-28.7%
—
—
$218M
2021
$583M
$8M
79.2%
1.8%
—
—
$219M
2020
$614M
-$18M
78.6%
-3.2%
-$22M
—
$187M
2019
$430M
-$23M
77.7%
-5.6%
-$12M
$50M
$645M
2018
$229M
-$116M
76.2%
-47.2%
-$95M
$80M
$249M
2017
$181M
-$68M
75.2%
-25.2%
-$33M
$92M
$74M
2016
$130M
-$86M
73.6%
-50.4%
-$72M
$94M
$98M
2015
—
-$115M
—
—
—
$92M
$107M
2014
—
-$56M
—
—
—
$105M
$120M
2013
—
-$166M
—
—
-$190M
$101M
$192M
2012
—
-$179M
—
—
-$123M
$85M
$260M
2011
—
-$69M
—
—
-$40M
—
$117M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$45M
-$11M
39.4%
-25.1%
—
—
$131M
Dec '25
$49M
-$1M
47.1%
-12.9%
—
—
$135M
Sep '25
$50M
-$8M
44.7%
-22.4%
—
—
$123M
Jun '25
$73M
-$14M
69.2%
-22.0%
—
—
$148M
Mar '25
$42M
-$16M
59.8%
-39.9%
—
—
$120M
Dec '24
$62M
-$49M
-15.4%
-84.3%
—
—
$121M
Sep '24
$42M
-$25M
38.5%
-59.5%
—
—
$157M
Jun '24
$67M
$2M
63.4%
-0.8%
—
—
$216M
Mar '24
$57M
-$10M
56.4%
-24.0%
—
—
$214M
Dec '23
$75M
-$6M
60.4%
-6.5%
—
—
$199M
Sep '23
$66M
-$19M
45.1%
-32.5%
—
—
$271M
Jun '23
$80M
-$18M
53.2%
-29.9%
—
—
$233M
Mar '23
$86M
-$16M
55.7%
-20.2%
—
—
$191M
Dec '22
$90M
$856000
70.5%
-10.6%
—
—
$218M
Sep '22
$90M
-$5M
69.9%
-5.7%
—
—
$240M
Jun '22
$94M
-$70M
46.2%
-66.5%
—
—
$228M
Mar '22
$95M
-$32M
76.5%
-29.9%
—
—
$219M
Dec '21
$144M
$15M
78.8%
11.2%
—
—
$219M
Sep '21
$142M
-$13M
78.7%
-9.2%
—
—
$223M
Jun '21
$154M
$8M
79.2%
5.7%
—
—
$327M
Valuation over time
How the market has priced AMRN against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has risen from 1.7× (Mar '23) to 32.2× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is AMRN growing its revenue and profit?
Over the past 5 years, AMARIN CORP PLCUK's revenue has declined 19.0% per year. These are computed facts, not advice.
How much debt does AMRN have?
As of FY2025, AMARIN CORP PLCUK reported — of total debt against $135M of cash; operating income covered interest expense -7167.1×.
What is AMRN's profit margin?
In FY2025, gross margin was 56.6%, operating margin -23.5%, and net margin -18.2%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.